PGAM2 Human

Phosphoglycerate Mutase 2 Human Recombinant
Cat. No.
BT12810
Source
Escherichia Coli.
Synonyms
Phosphoglycerate mutase 2, BPG-dependent PGAM 2, Muscle-specific phosphoglycerate mutase, Phosphoglycerate mutase isozyme M, PGAM-M, PGAM2, PGAMM, GSD10.
Appearance
Sterile Filtered colorless solution.
Purity
Greater than 95.0% as determined by SDS-PAGE.
Usage
THE BioTek's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.
Shipped with Ice Packs
In Stock

Description

PGAM2 Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing 273 amino acids (1-253) and having a molecular mass of 30.9kDa.
PGAM2 is fused to a 20 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques.

Product Specs

Introduction
Phosphoglycerate mutase 2 (PGAM2) is a member of the phosphoglycerate mutase family. This enzyme exists in different isoforms depending on the tissue, with a slow-migrating muscle (MM) isozyme, a fast-migrating brain (BB) isozyme, and a hybrid form (MB) present in varying ratios. PGAM catalyzes the reversible conversion of 3-phosphoglycerate (3-PGA) to 2-phosphoglycerate (2-PGA) within the glycolytic pathway. Mutations in the PGAM2 gene can lead to muscle phosphoglycerate mutase deficiency, also known as glycogen storage disease X.
Description
Recombinant human PGAM2, expressed in E. coli, is a single, non-glycosylated polypeptide chain. It consists of 273 amino acids (residues 1-253) with a molecular weight of 30.9 kDa. This protein includes a 20 amino acid His-tag fused at the N-terminus and is purified using proprietary chromatographic techniques.
Physical Appearance
A clear, colorless, and sterile-filtered solution.
Formulation
The provided PGAM2 solution has a concentration of 1mg/ml and is formulated in a buffer containing 20mM Tris-HCl (pH 8.0), 20% glycerol, 0.1M NaCl, and 1mM DTT.
Stability
For short-term storage (2-4 weeks), the product can be stored at 4°C. For extended storage, freezing at -20°C is recommended. The addition of a carrier protein (0.1% HSA or BSA) is advised for long-term storage. Repeated freezing and thawing should be avoided.
Purity
Purity is determined to be greater than 95.0% as assessed by SDS-PAGE analysis.
Synonyms
Phosphoglycerate mutase 2, BPG-dependent PGAM 2, Muscle-specific phosphoglycerate mutase, Phosphoglycerate mutase isozyme M, PGAM-M, PGAM2, PGAMM, GSD10.
Source
Escherichia Coli.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MATHRLVMVR HGESTWNQEN RFCGWFDAEL SEKGTEEAKR GAKAIKDAKM EFDICYTSVL KRAIRTLWAI LDGTDQMWLP VVRTWRLNER HYGGLTGLNK AETAAKHGEE QVKIWRRSFD IPPPPMDEKH PYYNSISKER RYAGLKPGEL PTCESLKDTI ARALPFWNEE IVPQIKAGKR VLIAAHGNSL RGIVKHLEGM SDQAIMELNL PTGIPIVYEL NKELKPTKPM QFLGDEETVR KAMEAVAAQG KAK.

Product Science Overview

Gene and Protein Structure

PGAM2 is encoded by the PGAM2 gene located on chromosome 7 in humans . The enzyme exists primarily as a dimer composed of two identical or closely related subunits, each with a molecular weight of approximately 32 kDa . The structure of PGAM2 is highly conserved across different species, from yeast to humans .

Isoforms and Tissue Specificity

There are two main isoforms of phosphoglycerate mutase in mammals: the brain-specific isoform (PGAM1) and the muscle-specific isoform (PGAM2) . PGAM2 is predominantly expressed in muscle tissues, where it plays a vital role in muscle metabolism .

Enzymatic Mechanism

PGAM2 functions as an isomerase, facilitating the internal transfer of a phosphate group from the C-3 carbon of 3-phosphoglycerate to the C-2 carbon, forming 2-phosphoglycerate . This reaction involves a 2,3-bisphosphoglycerate intermediate . The enzyme can also catalyze other reactions, including a phosphatase reaction that creates phosphoglycerate from 2,3-bisphosphoglycerate and a synthase reaction that produces 2,3-bisphosphoglycerate from 1,3-bisphosphoglycerate .

Clinical Significance

Mutations in the PGAM2 gene can lead to muscle phosphoglycerate mutase deficiency, also known as glycogen storage disease type X . This condition is characterized by muscle weakness and exercise intolerance due to impaired glycolysis in muscle cells .

Recombinant Production

Human recombinant PGAM2 is produced using recombinant DNA technology, which involves inserting the PGAM2 gene into an expression vector and introducing it into a host organism, such as bacteria or yeast, to produce the enzyme in large quantities. This recombinant enzyme is used in various biochemical and clinical research applications to study its structure, function, and role in metabolic pathways.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.